TD Securities upgraded shares of Vitalhub (TSE:VHI – Free Report) to a strong-buy rating in a research report released on Monday,Zacks.com reports.
Separately, Cormark raised their price objective on shares of Vitalhub from C$9.50 to C$10.50 and gave the stock a “buy” rating in a research note on Wednesday, October 2nd.
Vitalhub Trading Down 1.3 %
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Articles
- Five stocks we like better than Vitalhub
- What is a Dividend King?
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What Is WallStreetBets and What Stocks Are They Targeting?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What is a Death Cross in Stocks?
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.